Vector-borne diseases (VBDs) represent a significant public health challenge in India, responsible for substantial morbidity and mortality. This article aims to provide a comprehensive review of VBDs in India, with a focus on understanding their prevalence and developing effective strategies to combat them.
India's diverse topography and climatic conditions contribute to the prevalence of various VBDs. Malaria, dengue, and chikungunya are the most commonly reported, while emerging diseases like Zika and Kala-azar also pose significant threats. The World Health Organization estimates that India accounts for 89% of South-East Asia's VBDs, highlighting the urgency of addressing this issue.
Several factors contribute to the difficulty in managing VBDs in India. These include a lack of public awareness, inadequate health infrastructure, rapid urbanization, and climate change. Additionally, the high genetic variability of vectors and pathogens complicates the development of effective vaccines and therapeutics.
Efforts to control VBDs in India should focus on integrated vector management, including environmental management and biological control methods. Enhanced surveillance systems, community participation, and intersectoral coordination are crucial. Furthermore, investment in research and development for effective vaccines and therapeutics is imperative.
Healthcare professionals play a pivotal role in combating VBDs. They are instrumental in early detection and prompt treatment, reducing disease transmission. Additionally, they can contribute to public health education, promoting preventive measures and improving community engagement in control programs.
Addressing the burden of VBDs in India requires a comprehensive, multi-faceted approach. Understanding the epidemiology, overcoming challenges, and implementing effective control strategies are key. Healthcare professionals, with their unique roles and responsibilities, are critical in this endeavor, underscoring the need for continuous professional development in this area.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation